1/27
03:00 am
gnta
Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator
High
Report
Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator
1/19
08:32 am
gnta
Italy on the Move Brings 200+ Italy-US Biotech, Pharma and Investment Leaders Together in San Francisco During JPM Week
Low
Report
Italy on the Move Brings 200+ Italy-US Biotech, Pharma and Investment Leaders Together in San Francisco During JPM Week
12/19
06:15 am
gnta
Genenta Science Provides Update on CEO Ownership [Yahoo! Finance]
Low
Report
Genenta Science Provides Update on CEO Ownership [Yahoo! Finance]
12/19
02:30 am
gnta
Genenta Science Provides Update on CEO Ownership
Low
Report
Genenta Science Provides Update on CEO Ownership
12/9
04:24 pm
gnta
Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/27
02:47 pm
gnta
Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/24
04:00 am
gnta
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
Low
Report
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
11/21
01:59 pm
gnta
Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.